- Home
- IZEA vs TPST Comparison
IZEA vs TPST Comparison
Compare IZEA & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZEA
- TPST
- Stock Information
- Founded
- IZEA 2006
- TPST 2011
- Country
- IZEA United States
- TPST United States
- Employees
- IZEA N/A
- TPST N/A
- Industry
- IZEA Advertising
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- IZEA Consumer Discretionary
- TPST Health Care
- Exchange
- IZEA Nasdaq
- TPST Nasdaq
- Market Cap
- IZEA 44.6M
- TPST 33.0M
- IPO Year
- IZEA N/A
- TPST N/A
- Fundamental
- Price
- IZEA $3.72
- TPST $7.82
- Analyst Decision
- IZEA
- TPST Hold
- Analyst Count
- IZEA 0
- TPST 3
- Target Price
- IZEA N/A
- TPST $30.00
- AVG Volume (30 Days)
- IZEA 105.2K
- TPST 94.5K
- Earning Date
- IZEA 08-13-2025
- TPST 08-07-2025
- Dividend Yield
- IZEA N/A
- TPST N/A
- EPS Growth
- IZEA N/A
- TPST N/A
- EPS
- IZEA N/A
- TPST N/A
- Revenue
- IZEA $36,896,490.00
- TPST N/A
- Revenue This Year
- IZEA $16.46
- TPST N/A
- Revenue Next Year
- IZEA $15.95
- TPST N/A
- P/E Ratio
- IZEA N/A
- TPST N/A
- Revenue Growth
- IZEA 7.17
- TPST N/A
- 52 Week Low
- IZEA $1.68
- TPST $5.35
- 52 Week High
- IZEA $4.20
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- IZEA 65.71
- TPST 59.30
- Support Level
- IZEA $2.55
- TPST $7.13
- Resistance Level
- IZEA $4.07
- TPST $8.75
- Average True Range (ATR)
- IZEA 0.26
- TPST 0.45
- MACD
- IZEA 0.03
- TPST 0.13
- Stochastic Oscillator
- IZEA 65.98
- TPST 63.83
About IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.